MREO

Mereo BioPharma

MREO

Market cap $281M

64 hedge funds and large institutions have $182M invested in Mereo BioPharma in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 9 closing their positions.

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2

Holders

Holders Change

Holders Change %

+14.29%

% of All Funds

0.94%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

0.01%

New

Increased

Reduced

Closed

Calls

$2.22M

Puts

$107K

Net Calls

+$2.11M

Net Calls Change

+$1.45M

Top Buyers

1	MP 1 Mangrove Partners Greenwich, Connecticut	$20.2M
2	RCMNY 2 Rubric Capital Management (New York) New York	$31.3M
3	3 Adage Capital Partners Boston, Massachusetts	$6.12M
4	4 Aberdeen Group Edinburgh, United Kingdom	$3.58M
5	5 Alkeon Capital Management New York	$9.79M

Top Sellers

1	1 Citadel Advisors Miami, Florida	$750K
2	JGC 2 J. Goldman & Co New York	$374K
3	FAM 3 Formidable Asset Management Cincinnati, Ohio	$0
4	DCM 4 DAFNA Capital Management Los Angeles, California	$1.8M
5	5 JPMorgan Chase & Co New York	$44.2K

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	RCMNY 1 Rubric Capital Management (New York) New York	$31.3M	13,552,997	+1,936,877	+17%
2	SCM 2 Soleus Capital Management Greenwich, Connecticut	$22.6M	9,777,419	+100,000	+1%
3	MP 3 Mangrove Partners Greenwich, Connecticut	$20.2M	8,752,893	+3,221,346	+58%
4	RSCM 4 Rock Springs Capital Management Baltimore, Maryland	$18.4M	7,983,851	+307,370	+4%
5	SCM 5 Suvretta Capital Management New York	$17M	7,370,838	+6,400	+0.1%
6	6CM 6 683 Capital Management New York	$14.3M	6,200,000	+200,000	+3%
7	7 Alkeon Capital Management New York	$9.79M	4,238,100	+500,000	+13%
8	TC 8 Tejara Capital London, United Kingdom	$8.58M	3,713,129	+498,128	+15%
9	CC 9 Clearline Capital New York	$7.68M	3,326,718	+223,995	+7%
10	10 Adage Capital Partners Boston, Massachusetts	$6.12M	2,650,000	+1,850,000	+231%
11	11 Goldman Sachs New York	$4.67M	2,023,672	–	–
12	12 Renaissance Technologies New York	$4.15M	1,798,009	+70,439	+4%
13	13 Aberdeen Group Edinburgh, United Kingdom	$3.58M	1,551,082	+1,551,082	New
14	14 Millennium Management New York	$3.26M	1,410,317	+166,732	+13%
15	DCM 15 DAFNA Capital Management Los Angeles, California	$1.8M	778,813	-183,700	-19%
16	MAM 16 Monaco Asset Management Monaco	$1.56M	676,494	+80,765	+14%
17	NIM 17 NEOS Investment Management Westport, Connecticut	$813K	351,905	+310,577	+751%
18	18 Citadel Advisors Miami, Florida	$750K	324,819	-1,917,606	-86%
19	TI 19 Tidal Investments Milwaukee, Wisconsin	$738K	319,390	-12,524	-4%
20	20 Two Sigma Investments New York	$719K	311,060	+168,458	+118%
21	21 Susquehanna International Group Bala Cynwyd, Pennsylvania	$406K	175,628	+72,358	+70%
22	JGC 22 J. Goldman & Co New York	$374K	162,000	-283,485	-64%
23	KCM 23 Knoll Capital Management Miami, Florida	$370K	160,470	+160,470	New
24	24 Morgan Stanley New York	$352K	152,330	+145,637	+2,176%
25	FAM 25 Fred Alger Management New York	$237K	102,531	+102,531	New

Mereo BioPharma MREO Market cap $281M

Top Buyers

Top Sellers

Mereo BioPharma

MREO

Market cap $281M